IQVIA Holdings Inc.

IQV XNYS SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Market Cap

30B

Short interest (May 15)

3.0%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.31%

↓ 11.1%

Available Shares

3M

↓ 38.1%

Price Chart

Company Overview

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Company Info

Exchange: NYSE
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CIK: 0001478242
Asset Type: CS

Market Data

Market Cap: $30,148,815,999
Employees: 93,000
Status: Active

Short Interest

Current Borrow Fee 0.31%
Range: 0.25% - 0.31%
Available Shares 3M
Range: 2.5M - 2.6M

Recent Changes

Fee Change: ↑ 8.3%
Available Change: ↑ 8.2%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime